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DEAR EDITOR, Krypton chloride (KrCl) excimer lamps have a
peak emission wavelength of 222 nm, in the ultraviolet (UV)
C region of the electromagnetic spectrum. Currently KrCl
lamps are the only viable ‘far-UVC’ sources for full-room
inactivation of airborne SARS-CoV-2, the virus responsible for
the COVID-19 pandemic.1 Commercially available KrCl exci-
mer lamps can be retrofitted to existing room lamp fittings or
mounted at ceiling height independently. Other technologies,
such as light-emitting diodes, are currently neither efficient
nor powerful enough for such a task.
In addition to the peak KrCl excimer emission wavelength
of 222 nm (83% at 200–230 nm), the lamp spectrum con-
tains longer-wavelength UVC (10% at 230–280 nm), UVB
(3%) and UVA radiation (4%). These additional wavelengths
have been shown in vivo and in silico to penetrate to the skin’s
basal layer and cause DNA damage.2,3 When the excimer lamp
was filtered, reducing these longer wavelengths of UV radia-
tion, a study in 20 healthy volunteers did not show erythema
induction 24 h after exposure to 500 mJ cm2.4 In that study
there was a slight, statistically significant, increase in cyclobu-
tane pyrimidine dimers (CPDs) compared with nonirradiated
skin, although the location of these CPDs was not determined.
However, computer modelling and animal experiments sug-
gest that these CPDs will be limited in number and restricted
to the uppermost parts of the epidermis.2,5 The location of
CPDs is important as, if limited to the superficial suprabasal
nonproliferating skin cells, it is unlikely that this will indicate
a carcinogenic risk.6 To our knowledge, the location of CPDs
from filtered far-UVC radiation, as described above, has never
been demonstrated in human skin.
We performed human skin irradiation in two settings using
a filtered KrCl far-UVC source (SafeZoneUVC, Ushio Inc.,
Tokyo, Japan): firstly, in a novel ex vivo full-thickness human
skin model cultured at tension (manuscript in preparation)
and secondly, using in vivo self-exposures. Ex vivo human skin
was obtained from an abdominoplasty after full consent was
obtained. This skin was cultured at the air–liquid interface in
RM + medium containing 50 lg mL1 gentamicin, 200 U
mL1 penicillin, 200 lg mL1 streptomycin and 025
lg mL1 amphotericin B. There were three samples: an unir-
radiated negative control sample, a positive control sample
irradiated for 188 s delivering a radiant exposure of
515 mJ cm2 narrowband UVB (peak emission wavelength
311 nm, TL01; Philips, Eindhoven, the Netherlands) and the
test sample irradiated for 1000 s delivering a radiant exposure
of 6100 mJ cm2 filtered far-UVC. The human skin provider,
Biopredic International, holds permit AC-2013-1754 granted
by the French Ministry of Higher Education and Research for
the acquisition, transformation, sales and export of human
biological material for research.
In vivo, two of the authors irradiated their inner forearms at
a dose of 6100 mJ cm2 of filtered far-UVC, using the same
irradiation source and distance as the ex vivo samples. Ethical
approval was not required for self-exposures in the two senior
investigators who led the in vivo aspects of this work.
Punch biopsies (4 mm) were taken from irradiated sites
within 30 min of exposure and from nonirradiated sites, and
were fixed in freshly prepared 4% paraformaldehyde at 20°C
prior to paraffin embedding. CPD abundance was revealed by
immunohistochemical staining with monoclonal anti-thymine
dimer antibody (T1192; Sigma-Aldrich, St Louis, MO, USA).
Figure 1 displays histological staining of both the ex vivo and
irradiated in vivo skin. As would be expected, there is CPD for-
mation throughout the epidermis following narrowband UVB
irradiation in the ex vivo skin model (Figure 1b) and no CPDs
in the ex vivo control sample (Figure 1a). Both the ex vivo and
in vivo filtered far-UVC-irradiated human skin samples show
minimal CPD formation (Figure 1c and d, respectively).
Where CPD-positive cells were present in one volunteer,
importantly they were restricted to the upper layers of the epi-
dermis, with no basal-layer CPD formation detected. Fewer
CPD-positive cells were detected in the filtered far-UVC-irradi-
ated skin of the second volunteer, where a thicker stratum
corneum was evident, and both control in vivo samples were
CPD negative (data not shown).
This first-in-human demonstration of CPD location from fil-
tered far-UVC confirms the results of our previous in silico
model and indicates that the peak KrCl excimer emission
wavelength of 222 nm does not penetrate beyond the most
superficial epidermal layers.2 The ex vivo skin model was also
in agreement with the in vivo exposures, enabling us to under-
take future investigations that would be difficult to perform in
humans. The radiant exposure delivered in these experiments
is 265 times the current exposure limit value of 23 mJ cm2
at 222 nm.7 Therefore, even at very high exposure doses,
appropriately filtered far-UVC is unlikely to present a carcino-
genic risk through direct DNA damage. These important but
preliminary results are very encouraging. As recently advised
and encouraged by the UK’s Scientific Advisory Group for
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Emergencies we are continuing with multiple far-UVC
research projects to investigate the efficacy and safety profile
of this very promising technology.8 However, to date, the evi-
dence is overwhelmingly in favour of using filtered far-UVC
as a safe, effective germicidal technology.
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Figure 1 Histological staining. (a) Nonirradiated ex vivo skin sample. (b) Narrowband ultraviolet (UV)B-irradiated ex vivo skin sample. (c) Far-UVC-
irradiated ex vivo skin sample. (d) Far-UVC-irradiated in vivo human skin sample. Formalin-fixed paraffin-embedded skin samples were stained for
cyclobutane pyrimidine dimer (CPD) formation using immunohistochemical methods. Arrows are used to highlight examples of CPD-positive cells.
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